|Principal Investigator: Isaac Hall|
|Keywords: SARS-CoV-2 , COVID-19 , Vaccine , Antibody , Immunocompromised , Immunosuppression , Transplantation||Department: Nephrology|
|IRB Number: 00139840||Co Investigator: Hannah Imlay|
|Specialty: Nephrology and Hypertension, Nephrology and Hypertension, Nephrology and Hypertension, Nephrology and Hypertension|
|Sub Specialties: Dialysis, Pancreas Transplant, Kidney Transplant, General Neurology|
|Recruitment Status: Not yet recruiting|
To determine whether immune responses and side effect profiles differ between immunocompromised and healthy individuals.
We will adopt broad inclusion criteria because the goal of this study is to see whether COVID-19 vaccines result in different immune responses and side effects in immunocompromised individuals compared with healthy controls. Hence, we will include any patient clinically eligible to receive COVID-19 vaccination at the University of Utah. We will not restrict entry of patients into our study based on any demographic (other than age less than 12 years) or clinical parameters.
Age <12 years.